128 related articles for article (PubMed ID: 37192749)
1. Redispensing of expensive oral anticancer medicines: A practical application.
Akgöl K; van Merendonk LN; Barkman HJ; van Balen DE; van den Hoek HL; Klous MG; Hendrikx JJ; Huitema AD; Beijnen JH; Nuijen B
J Oncol Pharm Pract; 2024 Apr; 30(3):519-526. PubMed ID: 37192749
[TBL] [Abstract][Full Text] [Related]
2. Cost Savings and Waste Reduction Through Redispensing Unused Oral Anticancer Drugs: The ROAD Study.
Smale EM; van den Bemt BJF; Heerdink ER; Desar IME; Egberts TCG; Bekker CL;
JAMA Oncol; 2024 Jan; 10(1):87-94. PubMed ID: 37971730
[TBL] [Abstract][Full Text] [Related]
3. Actual versus recommended storage temperatures of oral anticancer medicines at patients' homes.
Vlieland ND; van den Bemt B; van Riet-Nales DA; Bouvy ML; Egberts A; Gardarsdottir H
J Oncol Pharm Pract; 2019 Mar; 25(2):382-389. PubMed ID: 29187027
[TBL] [Abstract][Full Text] [Related]
4. Redispensing of medicines unused by patients: a qualitative study among stakeholders.
Bekker CL; Gardarsdottir H; Egberts TC; Bouvy ML; van den Bemt BJ
Int J Clin Pharm; 2017 Feb; 39(1):196-204. PubMed ID: 28070689
[TBL] [Abstract][Full Text] [Related]
5. What does it cost to redispense unused medications in the pharmacy? A micro-costing study.
Bekker CL; Gardarsdottir H; Egberts ACG; Molenaar HA; Bouvy ML; van den Bemt BJF; Hövels AM
BMC Health Serv Res; 2019 Apr; 19(1):243. PubMed ID: 31014325
[TBL] [Abstract][Full Text] [Related]
6. Key factors underlying the willingness of patients with cancer to participate in medication redispensing.
Smale EM; Egberts TCG; Heerdink ER; van den Bemt BJF; Bekker CL
Res Social Adm Pharm; 2022 Aug; 18(8):3329-3337. PubMed ID: 34973931
[TBL] [Abstract][Full Text] [Related]
7. Patient and medication factors associated with preventable medication waste and possibilities for redispensing.
Bekker CL; van den Bemt BJF; Egberts ACG; Bouvy ML; Gardarsdottir H
Int J Clin Pharm; 2018 Jun; 40(3):704-711. PubMed ID: 29721736
[TBL] [Abstract][Full Text] [Related]
8. Adherence to oral anticancer chemotherapies and estimation of the economic burden associated with unused medicines.
Matti N; Delon C; Rybarczyk-Vigouret MC; Khan GM; Beck M; Michel B
Int J Clin Pharm; 2020 Oct; 42(5):1311-1318. PubMed ID: 32857257
[TBL] [Abstract][Full Text] [Related]
9. Willingness of patients to use unused medication returned to the pharmacy by another patient: a cross-sectional survey.
Bekker C; van den Bemt B; Egberts TC; Bouvy M; Gardarsdottir H
BMJ Open; 2019 May; 9(5):e024767. PubMed ID: 31092644
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness of therapeutic patient education on adherence to oral anti-cancer medicines in adult cancer patients in ambulatory care settings: a systematic review.
Arthurs G; Simpson J; Brown A; Kyaw O; Shyrier S; Concert CM
JBI Database System Rev Implement Rep; 2015 Jun; 13(5):244-92. PubMed ID: 26455611
[TBL] [Abstract][Full Text] [Related]
12. [Economic aspects in the care of patients with new oral anticancer drugs: findings from the AMBORA trial].
Dürr P; Schlichtig K; Krebs S; Schramm A; Schötz L; Fromm MF; Dörje F
Z Evid Fortbild Qual Gesundhwes; 2022 Apr; 169():84-93. PubMed ID: 35249863
[TBL] [Abstract][Full Text] [Related]
13. Factors Influencing Public Willingness to Reuse the Unused Stored Medications in Jordan: A Cross-Sectional Study.
Alhamad H; Jaber D; Abu-Farha R; Albahar F; Edaily SM; Donyai P
Healthcare (Basel); 2022 Dec; 11(1):. PubMed ID: 36611535
[TBL] [Abstract][Full Text] [Related]
14. Impact of use of oral anticancer drugs on activity of Italian oncology practices: results of a survey conducted by the Italian Society of Medical Oncology (AIOM).
Gori S; Di Maio M; Pinto C; Alabiso O; Baldini E; Barbato E; Beretta GD; Bravi S; Caffo O; Canobbio L; Carrozza F; Cinieri S; Cruciani G; Dinota A; Gebbia V; Giustini L; Graiff C; Molino A; Muggiano A; Pandoli G; Puglisi F; Tagliaferri P; Tomao S; Lunardi G; Venturini M;
Tumori; 2013; 99(1):35-8. PubMed ID: 23548997
[TBL] [Abstract][Full Text] [Related]
15. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
[TBL] [Abstract][Full Text] [Related]
16. A study on the quantity, type, economic value and reasons for pharmaceutical waste returned to pharmacies in Finland.
Louhisalmi M; Lavikainen P; Sandler C; Kallio S; Kanerva R; Martikainen J; Timonen J
Eur J Pharm Sci; 2024 Apr; 195():106729. PubMed ID: 38369170
[TBL] [Abstract][Full Text] [Related]
17. Operation Donate: defining the value of redispensing medications donated by individuals.
Glanville M; Brady R; Miller S
J Am Pharm Assoc (2003); 2014; 54(5):542-7. PubMed ID: 25216885
[TBL] [Abstract][Full Text] [Related]
18. An analysis of returned medicines in primary care.
Langley C; Marriott J; Mackridge A; Daniszewski R
Pharm World Sci; 2005 Aug; 27(4):296-9. PubMed ID: 16228627
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical counseling: Between evidence-based medicine and profits.
Egorova SN; Akhmetova T
Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
[TBL] [Abstract][Full Text] [Related]
20. Towards Medicines Reuse: A Narrative Review of the Different Therapeutic Classes and Dosage Forms of Medication Waste in Different Countries.
Alhamad H; Patel N; Donyai P
Pharmacy (Basel); 2020 Dec; 8(4):. PubMed ID: 33271889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]